The General Court has sided with EnBW Energie Baden-Wuerttemberg AG in its battle for documents related to a European Commission cartel investigation. The Court annuled the Commission’s decision to refuse access to the documents, rejecting the Commission’s argument that “the concept of ‘investigations’ cannot be limited, in the sphere of cartels, to the proceedings leading up to a decision prohibiting the cartel but must be regarded as an integral part of the Commission’s regular, ongoing task of enforcing EU competition law.” The Court found this interpretation to be too broad.
EnBW was the victim of a gas-insulated switchgear price-fixing cartel. The ten companies involved in the cartel were fined by the Commission in 2007. In the same year, EnBW sought access to the documents related to the proceedings, including the formal complaint and documents seized from the company offices, to prepare for its lawsuits against the companies for damages. The Commission resisted EnBW’s efforts, citing its need to protect immunity and leniency programs for whistle-blowers, as well as its own internal documents.
Full content: General Court judgment
Related content: A Joke: A Leniency Program Cartoon
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas